These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 11324144)

  • 1. [Sustaining remission in Crohn disease with methotrexate--a placebo controlled study].
    Roznowski AB; Dignass A
    Z Gastroenterol; 2001 Mar; 39(3):265-7. PubMed ID: 11324144
    [No Abstract]   [Full Text] [Related]  

  • 2. Methotrexate in Crohn's disease: results of a randomized, double-blind, placebo-controlled trial.
    Arora S; Katkov W; Cooley J; Kemp JA; Johnston DE; Schapiro RH; Podolsky D
    Hepatogastroenterology; 1999; 46(27):1724-9. PubMed ID: 10430331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues.
    Weiss B; Lerner A; Shapiro R; Broide E; Levine A; Fradkin A; Bujanover Y
    J Pediatr Gastroenterol Nutr; 2009 May; 48(5):526-30. PubMed ID: 19412004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Methotrexate in therapy of chronic inflammatory bowel diseases].
    Schröder O; Stein J
    Z Gastroenterol; 1996 Jul; 34(7):457-8. PubMed ID: 8928541
    [No Abstract]   [Full Text] [Related]  

  • 5. [Methotrexate treatment in Crohn disease].
    Mesnard B; Colombel JF; Cortot A; Chiche A; Gower-Rousseau C; Paris JC
    Gastroenterol Clin Biol; 1992; 16(2):190-1. PubMed ID: 1568549
    [No Abstract]   [Full Text] [Related]  

  • 6. [A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators].
    Martreau P
    Gastroenterol Clin Biol; 2000 Dec; 24(12):1243-4. PubMed ID: 11277090
    [No Abstract]   [Full Text] [Related]  

  • 7. [Methotrexate an alternative for young persons with Crohn disease].
    Hansson ME; Arebro J; Casswall T; Hessami M
    Lakartidningen; 2011 Apr 13-19; 108(15):860-3. PubMed ID: 21674974
    [No Abstract]   [Full Text] [Related]  

  • 8. Methotrexate for the maintenance of remission in Crohn's disease.
    Yang YX; Lichtenstein GR
    Gastroenterology; 2001 May; 120(6):1553-5. PubMed ID: 11313329
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fatal bone marrow aplasia after the 1st injection of methotrexate in a woman with Crohn's disease].
    Bellaïche G; Maisonneuve L; Nouts A; Ley G; Slama JL
    Gastroenterol Clin Biol; 1999 Oct; 23(10):1102-3. PubMed ID: 10592889
    [No Abstract]   [Full Text] [Related]  

  • 10. Methotrexate in Crohn's disease: long-term efficacy and toxicity.
    Lémann M; Zenjari T; Bouhnik Y; Cosnes J; Mesnard B; Rambaud JC; Modigliani R; Cortot A; Colombel JF
    Am J Gastroenterol; 2000 Jul; 95(7):1730-4. PubMed ID: 10925976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New therapeutic approaches to Crohn's disease.
    Sartor RB
    N Engl J Med; 2000 Jun; 342(22):1664-6. PubMed ID: 10833215
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of methotrexate in the management of Crohn disease.
    Ravikumara M; Hinsberger A; Spray CH
    J Pediatr Gastroenterol Nutr; 2007 Apr; 44(4):427-30. PubMed ID: 17414138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study.
    Lehman AJ; Esdaile JM; Klinkhoff AV; Grant E; Fitzgerald A; Canvin J;
    Arthritis Rheum; 2005 May; 52(5):1360-70. PubMed ID: 15880810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials.
    Sandborn WJ; Löfberg R; Feagan BG; Hanauer SB; Campieri M; Greenberg GR
    Am J Gastroenterol; 2005 Aug; 100(8):1780-7. PubMed ID: 16086715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recurrent aseptic osteonecrosis in Crohn's disease - extraintestinal manifestation or steroid related complication?].
    Lanyi B; Dienes HP; Kruis W
    Dtsch Med Wochenschr; 2005 Aug; 130(34-35):1944-7. PubMed ID: 16123897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease.
    Turner D; Grossman AB; Rosh J; Kugathasan S; Gilman AR; Baldassano R; Griffiths AM
    Am J Gastroenterol; 2007 Dec; 102(12):2804-12; quiz 2803, 2813. PubMed ID: 18042110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate in Crohn's disease.
    Rampton DS
    Gut; 2001 Jun; 48(6):790-1. PubMed ID: 11358896
    [No Abstract]   [Full Text] [Related]  

  • 18. Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn's disease: a double-blind placebo-controlled study.
    Omer B; Krebs S; Omer H; Noor TO
    Phytomedicine; 2007 Feb; 14(2-3):87-95. PubMed ID: 17240130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How effective are the usual treatments for Crohn's disease?
    Bebb JR; Scott BB
    Aliment Pharmacol Ther; 2004 Jul; 20(2):151-9. PubMed ID: 15233694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease.
    Reinisch W; Panés J; Lémann M; Schreiber S; Feagan B; Schmidt S; Sturniolo GC; Mikhailova T; Alexeeva O; Sanna L; Haas T; Korom S; Mayer H
    Am J Gastroenterol; 2008 Sep; 103(9):2284-92. PubMed ID: 18671816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.